Tag: Inclisiran

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Inclisiran

Alnylam Launches "Alnylam P5x25" Strategy for Planned Transition to a Top Five Biotech in Market ...

Added to Collection on: 2021-01-10 18:00:00

Tags for this article:

Branches of biology
Life Sciences
Biology
RNA
Gene expression
Molecular biology
Alnylam Pharmaceuticals
Therapeutic gene modulation
Small interfering RNA
Inclisiran
Lumasiran
Novartis
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
PCSK9 affects antitumor immunity

Added to Collection on: 2021-04-22 14:15:00

Tags for this article:

PCSK9 inhibitors
Monoclonal antibodies
Medical specialties
PCSK9
Drugs
Lipids
Evolocumab
Alirocumab
Low-density lipoprotein
Cholesterol
Inclisiran
Proprotein convertase
Xuhui Bao

Click the tags to see associated articles and topics

View Article Details
Homozygous Familial Hypercholesterolemia Market: Future Forecast Indicates a Growth Rate at a ...

Added to Collection on: 2021-06-15 16:52:30

Tags for this article:

Chemical compounds
Medical specialties
Health
PCSK9 inhibitors
Lipid metabolism disorders
Monoclonal antibodies
Sterols
Familial hypercholesterolemia
Alirocumab
PCSK9
Lipid-lowering agent
Inclisiran
Germany
Italy
Juxtapid
France
Japan
United States
United Kingdom
Evolocumab
Spain

Click the tags to see associated articles and topics

View Article Details
AZ and Ionis' PCSK9 cholesterol drug will not move to phase 3 - - Pharmaphorum

Added to Collection on: 2022-09-23 10:32:51

Tags for this article:

Lipids
Medical specialties
Branches of biology
PCSK9
Lipid metabolism disorders
Low-density lipoprotein
Cholesterol
Inclisiran
Hypercholesterolemia
AstraZeneca
Alirocumab
Bococizumab
Ionis
Novartis

Click the tags to see associated articles and topics

View Article Details
Inclisiran First Strategy Safe, Effective for LDL-C Control in ASCVD Patients - HCPLive

Added to Collection on: 2024-04-06 20:59:39

Tags for this article:

Cardiology
Lipoproteins
Lipid metabolism disorders
Statins
PCSK9 inhibitors
Inclisiran
Familial hypercholesterolemia
Low-density lipoprotein
PCSK9
High-density lipoprotein
Hypercholesterolemia
Cholesterol

Click the tags to see associated articles and topics

View Article Details
Challenges and opportunities for addressing hyperlipidemia in the primary prevention population

Added to Collection on: 2024-05-01 15:37:19

Tags for this article:

Statins
Lipid metabolism disorders
PCSK9 inhibitors
Hepatotoxins
Familial hypercholesterolemia
PCSK9
Low-density lipoprotein
Inclisiran
Alirocumab
Atorvastatin
Simvastatin
Hyperlipidemia
Case Western Reserve University

Click the tags to see associated articles and topics

View Article Details
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Added to Collection on: 2024-11-30 09:17:56

Tags for this article:

Lipid metabolism disorders
PCSK9 inhibitors
PCSK9
Familial hypercholesterolemia
ANGPTL3
Low-density lipoprotein
Verve PCSK9-inhibitor gene therapy
Hypercholesterolemia
Cholesterol
Inclisiran
Alnylam Pharmaceuticals
Verve Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Atherosclerotic Cardiovascular Disease Market Size to Reach USD 30.6 Billion by 2035 ...

Added to Collection on: 2025-02-17 14:24:50

Tags for this article:

PCSK9 inhibitors
Vascular diseases
Cardiology
Lipoproteins
Inclisiran
Small interfering RNA
PCSK9
Atherosclerosis
Low-density lipoprotein
Statin
Lipid-lowering agent
Cardiovascular disease
IMARC Group

Click the tags to see associated articles and topics

View Article Details
PCSK9 inhibitors: monoclonal antibodies or siRNA? - Medical Republic

Added to Collection on: 2025-03-28 07:37:25

Tags for this article:

PCSK9 inhibitors
Lipid metabolism disorders
Monoclonal antibodies
Statins
PCSK9
Inclisiran
Familial hypercholesterolemia
Alirocumab
Low-density lipoprotein
Evolocumab
Hypercholesterolemia
RNA interference

Click the tags to see associated articles and topics

View Article Details
Verve's shares jump by more than 26% on Lilly-partnered gene therapy data

Added to Collection on: 2025-04-14 19:29:03

Tags for this article:

PCSK9 inhibitors
PCSK9
Verve PCSK9-inhibitor gene therapy
Familial hypercholesterolemia
Low-density lipoprotein
Dyslipidemia
Alirocumab
Gene therapy
Evolocumab
Inclisiran
Eli Lilly and Company
Lipoprotein

Click the tags to see associated articles and topics

View Article Details